# Biomarkers in the Diagnosis and Prognosis of NAFLD

> **NCT06098417** · — · RECRUITING · sponsor: **University of Trieste** · enrollment: 500 (estimated)

## Conditions studied

- NAFLD
- Obesity
- Liver Fibrosis
- Diabetes Mellitus, Type 2

## Interventions

- **DIAGNOSTIC_TEST:** Plasma Test
- **DIAGNOSTIC_TEST:** Plasma test
- **DIAGNOSTIC_TEST:** Plasma test
- **DIAGNOSTIC_TEST:** Plasma test
- **DIAGNOSTIC_TEST:** Liver biopsy
- **DIAGNOSTIC_TEST:** Visceral adipose tissue biopsy
- **DIAGNOSTIC_TEST:** Liver elastography
- **DIAGNOSTIC_TEST:** Blood test

## Key facts

- **NCT ID:** NCT06098417
- **Lead sponsor:** University of Trieste
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-09-22
- **Primary completion:** 2025-09-22
- **Final completion:** 2026-09-22
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06098417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06098417, "Biomarkers in the Diagnosis and Prognosis of NAFLD". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06098417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*